The implications of antigenic diversity for vaccine development

This publication has 42 references indexed in Scilit:

• A Human Monoclonal Antibody Specific for the V3 Loop of HIV Type 1 Clade E Cross-Reacts with Other HIV Type 1 Clades
  AIDS Research and Human Retroviruses, 1998
• The Neutralization Relationship of HIV Type 1, HIV Type 2, and SIVcpz Is Reflected in the Genetic Diversity that Distinguishes Them
  AIDS Research and Human Retroviruses, 1997
• Diversity of Antibody Binding to V3 Peptides Representing Consensus Sequences of HIV Type 1 Genotypes A to E: An Approach for HIV Type 1 Serological Subtyping
  AIDS Research and Human Retroviruses, 1996
• Reduced Capacity of Antibodies from Patients Infected with Human Immunodeficiency Virus Type 1 (HIV-l) Group 0 to Neutralize Primary Isolates of HIV-1 Group M Viruses
  The Journal of Infectious Diseases, 1995
• Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.
  The Journal of Experimental Medicine, 1995
• Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
  Science, 1994
• Genotypic subtypes of HIV-1 in Cameroon
  AIDS, 1994
• Further evidence of the presence of genetically aberrant HIV-1 strains in Cameroon and Gabon
  AIDS, 1994
• Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes
  AIDS, 1993
• The Emergence of Simian/Human Immunodeficiency Viruses
  AIDS Research and Human Retroviruses, 1992